Overview of the Global Market for Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

Market Size for Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

The global human and animal blood market stood at $X in 2022, increasing by X% against the previous year. Over the period under review, the total consumption indicated a remarkable increase from 2012 to 2022: its value increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, consumption decreased by X% against 2020 indices. As a result, consumption attained the peak level of $X. From 2021 to 2022, the growth of the global market failed to regain momentum.

Production of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

In value terms, human and animal blood production reached $X in 2022 estimated in export price. Over the period under review, production saw a buoyant increase. The most prominent rate of growth was recorded in 2017 with an increase of X%. Over the period under review, global production reached the maximum level at $X in 2020; however, from 2021 to 2022, production remained at a lower figure.

Exports of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

Exports

In 2022, after six years of growth, there was significant decline in overseas shipments of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses, when their volume decreased by X% to X tons. Overall, exports, however, saw a resilient increase. The pace of growth appeared the most rapid in 2021 when exports increased by X% against the previous year. As a result, the exports reached the peak of X tons, and then reduced notably in the following year.

In value terms, human and animal blood exports fell rapidly to $X in 2022. In general, exports, however, enjoyed a notable expansion. The most prominent rate of growth was recorded in 2021 with an increase of X% against the previous year. As a result, the exports reached the peak of $X, and then dropped sharply in the following year.

Exports by Country

In 2022, the United States (X tons) and the UK (X tons) were the main exporters of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic usesaround the world, together comprising X% of total exports. The Netherlands (X tons) ranks next in terms of the total exports with a X% share, followed by Singapore (X%), France (X%) and New Zealand (X%). Argentina (X tons), Canada (X tons), India (X tons), Spain (X tons), Denmark (X tons), Ireland (X tons) and Italy (X tons) took a minor share of total exports.

From 2012 to 2022, the most notable rate of growth in terms of shipments, amongst the main exporting countries, was attained by Singapore (with a CAGR of X%), while the other global leaders experienced more modest paces of growth.

In value terms, the United States ($X) emerged as the largest human and animal blood supplier worldwide, comprising X% of global exports. The second position in the ranking was held by the UK ($X), with a X% share of global exports. It was followed by Ireland, with an X% share.

From 2012 to 2022, the average annual rate of growth in terms of value in the United States amounted to X%. In the other countries, the average annual rates were as follows: the UK (X% per year) and Ireland (X% per year).

Export Prices by Country

In 2022, the average human and animal blood export price amounted to $X per ton, with a decrease of X% against the previous year. Overall, the export price recorded a slight slump. The most prominent rate of growth was recorded in 2015 an increase of X%. The global export price peaked at $X per ton in 2021, and then reduced notably in the following year.

There were significant differences in the average prices amongst the major exporting countries. In 2022, amid the top suppliers, the country with the highest price was Ireland ($X per ton), while New Zealand ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by France (X%), while the other global leaders experienced more modest paces of growth.

Imports of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

Imports

In 2022, purchases abroad of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses decreased by X% to X tons for the first time since 2015, thus ending a six-year rising trend. In general, total imports indicated a moderate expansion from 2012 to 2022: its volume increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. The pace of growth was the most pronounced in 2021 when imports increased by X% against the previous year. As a result, imports attained the peak of X tons, and then contracted significantly in the following year.

In value terms, human and animal blood imports reduced sharply to $X in 2022. Overall, imports, however, showed a relatively flat trend pattern. The pace of growth was the most pronounced in 2017 with an increase of X%. Global imports peaked at $X in 2021, and then dropped remarkably in the following year.

Imports by Country

In 2022, Canada (X tons), distantly followed by France (X tons) and Guatemala (X tons) represented the key importers of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses, together committing X% of total imports. The following importers - the Netherlands (X tons), Australia (X tons), Sweden (X tons), Austria (X tons), the UK (X tons), the United States (X tons), Brazil (X tons), India (X tons), Spain (X tons) and Ecuador (X tons) - together made up X% of total imports.

From 2012 to 2022, average annual rates of growth with regard to human and animal blood imports into Canada stood at X%. At the same time, Guatemala (X%), India (X%), Ecuador (X%), Australia (X%), the Netherlands (X%), France (X%), Sweden (X%), the UK (X%) and Spain (X%) displayed positive paces of growth. Moreover, Guatemala emerged as the fastest-growing importer imported in the world, with a CAGR of X% from 2012-2022. Brazil experienced a relatively flat trend pattern. By contrast, the United States (X%) and Austria (X%) illustrated a downward trend over the same period. Canada (X p.p.), Guatemala (X p.p.), France (X p.p.), Australia (X p.p.), the Netherlands (X p.p.), India (X p.p.) and Ecuador (X p.p.) significantly strengthened its position in terms of the global imports, while Brazil, the United States and Austria saw its share reduced by X%, X% and X% from 2012 to 2022, respectively. The shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, the largest human and animal blood importing markets worldwide were the United States ($X), Sweden ($X) and the UK ($X), with a combined X% share of global imports. France, Canada, the Netherlands, Guatemala, India, Australia, Brazil, Spain, Ecuador and Austria lagged somewhat behind, together accounting for a further X%.

Guatemala, with a CAGR of X%, recorded the highest rates of growth with regard to the value of imports, among the main importing countries over the period under review, while purchases for the other global leaders experienced more modest paces of growth.

Import Prices by Country

The average human and animal blood import price stood at $X per ton in 2022, dropping by X% against the previous year. Overall, the import price saw a pronounced reduction. The pace of growth was the most pronounced in 2018 an increase of X%. Over the period under review, average import prices hit record highs at $X per ton in 2012; however, from 2013 to 2022, import prices stood at a somewhat lower figure.

There were significant differences in the average prices amongst the major importing countries. In 2022, amid the top importers, the country with the highest price was the United States ($X per ton), while Austria ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by the Netherlands (X%), while the other global leaders experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :